CAN FITE BIOPHARMA LTD (CANF)
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Can-Fite Secures Japanese Patent Allowance for Namodenosons Anti-Obesity Technology
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
Tilray Medical Expands Medical Cannabis Access for Veterans Through Lyphe Clinic at Aldershot’s Armed Forces Weekend
New Autism Research to be Presented at European Purine Scientific Meeting
Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update
Kyivstar and Ukraine’s Securities Regulator Sign Memorandum to Advance Capital Markets Development and Expand Investment Access
Fury Announces Results of Annual General Meeting of Shareholders
Mandatory Cash Dividend/ Distribution:
General Announcement: Net Asset Value Per Unit
DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP